Cancer biomarker detection
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- DESTINA GENOMICA SLNE
Spanish biotech SME developing peptide nucleic acid-based biosensors for liquid biopsy cancer diagnostics and infectious disease detection.
“Projects miRNA-DisEASY, Liqbiopsens, and diaRNAgnosis all target cancer biomarkers across colorectal, prostate, and testicular cancers.”
PrimarySMEES5 projects - BRACCO IMAGING SPA
Italian diagnostic imaging company contributing MRI and CT contrast expertise to cancer detection and cardiovascular imaging research.
“GLINT focused on imaging neoplastic tumours using metabolic biomarkers, combining imaging physics with oncology.”
IT3 projects - DATAMEDRIX GMBH
Vienna biomedical SME specializing in liquid biopsy platforms, RNA cancer diagnostics, and tau protein structural analysis.
“diaRNAgnosis addresses prostate and testicular cancer biomarkers using peptide nucleic acid-based sensor platforms.”
PrimarySMEAT2 projects